At a recent event researcher and founder of Bit.bio, Prof. Mark Kotter, Babraham Research Campus in Cambridge/UK, was asked what healthcare looks like in 2050. He gave a twofold answer, that it will be driven by data, but also will be personalised. Mark Kotter elaborates here in more detail what is needed to unlock a healthcare of tomorrow.
Unitaid awards Medincell US$6m to fight malaria
Latest NewsGlobal health agency Unitaid has awarded French Medincell Corp (Jacou) an extension grant of up to US$ 6 million over three years to fund thesatety testing of its malaria vaccine mdc-STM.
Genmab broadens ADC pipeline with $1.8bn acquisition of ProfoundBio
Latest NewsGenmab announced today that it will acquire privately held biotech company ProfoundBio for $1.8bn in cash. The deal is designed to help the Danish pharmaceutical company deepen its cancer pipeline with next-generation antibody-drug conjugate therapies where the company has already an inlicensing deal with former Synaffix´s ADC technology platform (which was acquired mid of 2023 by Lonza).
TME Pharma gets FDA Fast Track for Glioblastoma
Latest NewsTME Pharma (France/Germany) announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for NOX-A12 (olaptesed pegol), TME Pharma’s CXCL12 inhibitor, in combination with radiotherapy and bevacizumab for use in the treatment of the aggressive adult brain cancer glioblastoma.
Biology as Software
BackgroundAt a recent event researcher and founder of Bit.bio, Prof. Mark Kotter, Babraham Research Campus in Cambridge/UK, was asked what healthcare looks like in 2050. He gave a twofold answer, that it will be driven by data, but also will be personalised. Mark Kotter elaborates here in more detail what is needed to unlock a healthcare of tomorrow.
Chemspec Europe 2024
Sponsored PublicationsConnect with the world of fine and speciality chemicals: taking place from 19-20 June 2024 at the Messe Düsseldorf exhibition centre in Germany, Chemspec Europe is the key marketplace to showcase the full array of fine and speciality chemicals, bespoke solutions, services, and equipment.
Forbion participates in US financing rounds
Latest NewsForbion, the European life sciences venture capital firm from The Netherlands, announced its participation in oversubscribed Series B financing in Capstan Therapeutics Inc. and Engrail Therapeutics. Both companies are located in San Diego, USA.
Richter-Helm – how CDMOs become strong partners
BackgroundProfessionalism and quality are always at the forefront along the whole value chain: from gene to product. To pro-actively meet the evolving demand of the market to produce new assets Richter-Helm significantly increased its manufacturing capacities for biopharmaceutical products at its production site in Bovenau, Germany.
New law to speed up clinical trials
Latest NewsWith a new law, the German government wants to increase the number of clinical trials conducted in Germany and make the country number one in Europe again.
Gut bacteria seed autoimmunity-inducers
Latest NewsA bacterium of the gut microbiome seems to spark an autoimmune disease in the kidneys by leaking antigens that trigger the immune system.
Innocent Meat bags €3m financing
Latest NewsCultivated meat producer Innocent Meat GmbH has cashed in €3m in funding from Venture Capital Fonds MV and an anonymous business angel.